Early urinary catheter removal in patients undergoing rectal cancer surgery: a randomized controlled trial on silodosin versus no pharmacological treatment on urinary function in the early postoperative period
Early urinary catheter removal on the first postoperative day was safe in both groups. The use of the oral α-antagonist silodosin did not provide additional benefits in preventing lower urinary tract symptoms in patients undergoing rectal cancer surgery. Trial registration: ClinicalTrials.gov identifier: NCT03607370.
Authors
- Žilvinas Gricius
- Justas Kuliavas (ORCID: https://orcid.org/0000-0001-8503-1495)
- Audrius Dulskas (ORCID: https://orcid.org/0000-0003-3692-8962)
- Eugenijus Stratilatovas
- Bronius Buckus
Institutions
- Vilnius University (LT)
- Vilnius University of Applied Sciences (LT)
- SMK University of Applied Social Sciences (LT)
- National Cancer Institute (LT)
Publication Details
- Journal
- Annals of Coloproctology
- Published
- 2025-06-20
- DOI
- https://doi.org/10.3393/ac.2024.00703.0100
- Citations
- 1
- Primary Topic
- Bladder and Urothelial Cancer Treatments
- Type
- article
- Field-Weighted Citation Impact
- 2.01